# Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis

> **NCT04384458** · NA · UNKNOWN · sponsor: **Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara** · enrollment: 400 (estimated)

## Conditions studied

- Coronavirus Infections

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Ivermectin

## Key facts

- **NCT ID:** NCT04384458
- **Lead sponsor:** Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-20
- **Primary completion:** 2020-09-10
- **Final completion:** 2021-04
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2020-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04384458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04384458, "Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04384458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*